MoneyWorks4Me

Sigachi Industries - Quaterly Results

25 May 2023 Evaluate
The March 2023 quarter revenue stood at Rs. 760.80 millions, up 7.35% as compared to Rs. 708.70 millions during the corresponding quarter last year.The Company's Net profit for the March 2023 quarter have declined marginally to Rs. 94.29  millions as against Rs. 104.26 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 155.53 millions from 149.38 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 760.80 708.70 7.35 2903.24 2494.05 16.41 2903.24 2494.05 16.41
Other Income 15.50 17.29 -10.35 66.72 26.30 153.69 66.72 26.30 153.69
PBIDT 155.53 149.38 4.12 624.85 530.25 17.84 624.85 530.25 17.84
Interest 14.12 4.75 197.26 42.87 11.55 271.17 42.87 11.55 271.17
PBDT 141.41 144.63 -2.23 581.98 518.70 12.20 581.98 518.70 12.20
Depreciation 19.75 8.00 146.88 66.21 29.05 127.92 66.21 29.05 127.92
PBT 121.66 136.63 -10.96 515.77 489.65 5.33 515.77 489.65 5.33
TAX 27.37 32.37 -15.45 100.18 109.37 -8.40 100.18 109.37 -8.40
Deferred Tax 6.06 4.75 27.58 -2.06 10.53 -119.56 -2.06 10.53 -119.56
PAT 94.29 104.26 -9.56 415.59 380.28 9.29 415.59 380.28 9.29
Equity 307.43 307.43 0.00 307.43 307.43 0.00 307.43 307.43 0.00
PBIDTM(%) 20.44 21.08 -3.01 21.52 21.26 1.23 21.52 21.26 1.23
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..